Glaxo Grp England Drug Patent Portfolio
Glaxo Grp England owns 1 orange book drug protected by 11 US patents Given below is the list of Glaxo Grp England's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8746242 | Medicament dispenser | 11 Oct, 2030 | Active |
| US8534281 | Manifold for use in medicament dispenser | 08 Mar, 2030 | Active |
| US8201556 | Medicament dispenser | 05 Feb, 2029 | Active |
| US8161968 | Medicament dispenser | 05 Feb, 2028 | Active |
| US7488827 | Muscarinic acetylcholine receptor antagonists | 18 Dec, 2027 | Active |
| US8113199 | Counter for use with a medicament dispenser | 23 Oct, 2027 | Active |
| US9333310 | Medicament dispenser | 02 Oct, 2027 | Active |
| US8183257 | Muscarinic acetylcholine receptor antagonists | 27 Jul, 2025 | Active |
| US7498440 | Muscarinic acetylcholine receptor antagonists | 27 Apr, 2025 | Active |
| US8309572 | Muscarinic acetylcholine receptor antagonists | 27 Apr, 2025 | Active |
| US5873360 | Inhalation device | 23 Feb, 2016 | Expired |
Latest Legal Activities on Glaxo Grp England's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Glaxo Grp England.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 19 Apr, 2024 | US8309572 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Nov, 2023 | US8201556 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Oct, 2023 | US9333310 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 19 Oct, 2023 | US8183257 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Sep, 2023 | US8161968 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Jul, 2023 | US8113199 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Nov, 2021 | US8746242 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2020 | US8534281 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Aug, 2020 | US7498440 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Jul, 2020 | US7488827 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Apr, 2020 | US8309572 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Nov, 2019 | US8201556 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Oct, 2019 | US8183257 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Oct, 2019 | US9333310 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 Sep, 2019 | US8161968 |
Glaxo Grp England Drug Patents' Oppositions Filed in EPO
Glaxo Grp England drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Apr 17, 2020, by Elkington And Fife Llp. This opposition was filed on patent number EP06765149A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP06765149A | Apr, 2020 | ELKINGTON AND FIFE LLP | Patent maintained as amended |
Glaxo Grp England's Family Patents
Glaxo Grp England Drug List
Given below is the complete list of Glaxo Grp England's drugs and the patents protecting them.
1. Incruse Ellipta
Incruse Ellipta is protected by 11 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8746242 | Medicament dispenser |
11 Oct, 2030
(5 years from now)
| Active |
| US8534281 | Manifold for use in medicament dispenser |
08 Mar, 2030
(5 years from now)
| Active |
| US8201556 | Medicament dispenser |
05 Feb, 2029
(4 years from now)
| Active |
| US8161968 | Medicament dispenser |
05 Feb, 2028
(3 years from now)
| Active |
| US7488827 | Muscarinic acetylcholine receptor antagonists |
18 Dec, 2027
(3 years from now)
| Active |
| US8113199 | Counter for use with a medicament dispenser |
23 Oct, 2027
(2 years from now)
| Active |
| US9333310 | Medicament dispenser |
02 Oct, 2027
(2 years from now)
| Active |
| US8183257 | Muscarinic acetylcholine receptor antagonists |
27 Jul, 2025
(8 months from now)
| Active |
| US7498440 | Muscarinic acetylcholine receptor antagonists |
27 Apr, 2025
(5 months from now)
| Active |
| US8309572 | Muscarinic acetylcholine receptor antagonists |
27 Apr, 2025
(5 months from now)
| Active |
| US5873360 | Inhalation device |
23 Feb, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Incruse Ellipta's drug page